Entyvio
vedolizumab · Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous
No FDA structured label text is available for Entyvio. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Vedolizumab in 2 products
Entyvio NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 64764-107 | Vedolizumab 108 mg/.68mL Injection, Solution | Takeda Pharmaceuticals America, Inc. | BLA |
| 64764-300 | Vedolizumab 300 mg/5mL Injection, Powder, Lyophilized, For Solution | Takeda Pharmaceuticals America, Inc. | BLA |
Frequently asked questions
Who makes Entyvio?
Entyvio is listed by 1 labeler in the FDA NDC directory, including Takeda Pharmaceuticals America, Inc..